uniQure (QURE) EBIT Margin (2016 - 2026)

uniQure (QURE) posted quarterly EBIT Margin of 893.73% for Q2 2026, down 6012.0% year-over-year from 15.12% in Q2 2025, and up 30.37% quarter-over-quarter from 1283.55% in Q1 2026.

uniQure (QURE) EBIT Margin (2016 - 2026) Analysis & Trends

uniQure's EBIT Margin history runs 11 years deep, the most recent figure standing at 893.73% for Q2 2026.

  • In Q2 2026, EBIT Margin fell 6012.0% year-over-year to 893.73%; the TTM figure through Jun 2026 stood at 1071.53% (up 10900.0% YoY), while the FY2025 annual figure was 1151.38%, down 47180.0% from the prior year.
  • EBIT Margin for Q2 2026 stood at 893.73%, up from 1283.55% in the prior quarter.
  • The five-year high for EBIT Margin was 25.79% in Q4 2022, with the low at 11279.88% in Q2 2022.
  • The 5-year median for EBIT Margin is 1331.25% (2025), against an average of 2260.6%.
  • The sharpest annual moves came in 2022 and 2023: EBIT Margin tumbled 1136568 bps in 2022, then jumped 859309 bps in 2023.
  • uniQure's EBIT Margin stood at 25.79% in 2022, then plunged by 3679 bps to 923.13% in 2023, then gained by 5 bps to 877.76% in 2024, then retreated by 5 bps to 918.07% in 2025, then grew by 3 bps to 893.73% in 2026.
  • Business Quant data shows QURE's EBIT Margin at 893.73% in Q2 2026, 1283.55% in Q1 2026, and 918.07% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.15%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 31.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 19.06%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -105.20%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 19.75%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 17.93%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.36%
10 uniQure 3.37 Bn 3.37 Bn 5.49 Mn -893.73%

Historic Data

Download Data
DateValue
Jun 30, 2026 -893.73%
Mar 31, 2026 -1,283.55%
Dec 31, 2025 -918.07%
Sep 30, 2025 -1,378.95%
Jun 30, 2025 -833.62%
Mar 31, 2025 -2,509.96%
Dec 31, 2024 -877.76%
Sep 30, 2024 -1,758.99%
Jun 30, 2024 -395.56%
Mar 31, 2024 -639.10%
Dec 31, 2023 -923.13%
Sep 30, 2023 -5,819.26%
Jun 30, 2023 -2,686.79%
Mar 31, 2023 -1,392.90%
Dec 31, 2022 25.79%
Sep 30, 2022 -4,107.52%
Jun 30, 2022 -11,279.88%
Mar 31, 2022 -3,017.86%
Dec 31, 2021 3.58%
Sep 30, 2021 -2,262.44%